Red Violet
Valuation each multiple against its own 5-year range
Vs. peers Software - Application
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Red Violet (RDVT) | 1.09B | 57.24 | 4.80 | 0.00% |
| SAP SE (SAP) | 229.61B | 26.25 | 4.56 | 1.43% |
| Shopify (SHOP) | 159.17B | 75.90 | 12.48 | 0.00% |
| Salesforce (CRM) | 148.65B | 16.54 | 3.87 | 0.95% |
| Uber Technologies (UBER) | 129.60B | 37.34 | 4.69 | 0.00% |
| Automatic Data Processing (ADP) | 119.10B | 26.75 | 23.39 | 2.25% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 7.9% below Morningstar's fair value estimate.
Fair value
Red Violet Inc receives a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a price consistent with our quantitative fair value estimate, which has a medium uncertainty rating.
The company's lack of profitability weakens our quantitative valuation. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. For example, the firm's sales yield of 10.1% lies in the bottom 10% globally. This company's inability to generate significant sales growth without meaningful capital investment is a challenge, which contributes to our balanced fair value estimate.
The firm's unfavorable dividend structure is an additional cause for concern. Dividends represent a stable form of future cash flows returned to shareholders, and low dividend payments can increase the perceived risk of a business. The firm's forward dividend yield of 0%, for example, ranks in the bottom 30% compared with peers globally. This could imply a planned dividend cut or relatively high share price, which further promotes our neutral price/fair value ratio.
Economic moat
The company's narrow economic moat rating suggests it should be able to maintain robust profitability for a decade or longer before competition erodes its advantage. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.
By Quantitative Equity Report
Quote time 2026-11-20 20:02:43 · For reference only, not investment advice and not tailored to your situation.
Red Violet discussion 0 comments